Aurora Cannabis Inc SEC Filings

ACB NASDAQ

Welcome to our dedicated page for Aurora Cannabis SEC filings (Ticker: ACB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Valuing living cannabis plants, tracking cultivation costs, and monitoring shifting international licences make Aurora Cannabis Inc. (ACB) one of the more intricate reads on EDGAR. If you have ever opened the annual report and wondered where the biological-asset re-measurements hide, or searched Form 4s for cultivation executives buying shares ahead of a Health Canada decision, you know the challenge.

Stock Titan solves it. Our AI turns the dense language of each Aurora Cannabis annual report 10-K simplified, Aurora Cannabis quarterly earnings report 10-Q filing, and every Aurora Cannabis 8-K material events explained into clear takeaways—often in seconds. You’ll see Aurora Cannabis insider trading Form 4 transactions in real time, get alerts for Aurora Cannabis executive stock transactions Form 4, and browse a single timeline that covers proxy statement executive compensation details, prospectuses, and registration statements. Need quick context? Choose “understanding Aurora Cannabis SEC documents with AI” and our engine highlights segment margins, fair-value gains, and licence updates without the jargon.

Whether you are comparing biological-asset write-downs quarter over quarter or scanning the Aurora Cannabis proxy statement executive compensation before voting, our platform keeps every disclosure at your fingertips and constantly updated. Practical uses include:

Monitoring Aurora Cannabis Form 4 insider transactions real-time for buying and selling patterns
Running Aurora Cannabis earnings report filing analysis to spot margin shifts
Setting alerts for new cultivation facility disclosures or international export approvals

No more digging through hundreds of pages; our AI-powered summaries, expert context, and real-time feeds surface the information that drives informed decisions.

06/20/2025 06:46 AM

Filing

[6-K] Aurora Cannabis Inc. Current Report (Foreign Issuer)

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

[6-K] Aurora Cannabis Inc. Current Report (Foreign Issuer)

Rhea-AI Summary

Overview: Aurora Cannabis Inc. (ACB) filed a Form 6-K for the month of June 2025.

The filing is purely procedural and furnishes Exhibit 99.1—a news release dated 18 June 2025—without reproducing the release’s contents. No financial statements, earnings figures, or strategic transaction details are included. The cover page confirms that the company continues to file annual reports under Form 40-F and that Chief Executive Officer Miguel Martin signed the submission on 18 June 2025.

Investor takeaway: Because the underlying press release is not provided, this 6-K offers no quantitative data or substantive operational updates. It should therefore be viewed as routine compliance rather than a market-moving disclosure.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-20.41%

FAQ

What is the current stock price of Aurora Cannabis (ACB)?

The current stock price of Aurora Cannabis (ACB) is $4.15 as of June 28, 2025.

What is the market cap of Aurora Cannabis (ACB)?

The market cap of Aurora Cannabis (ACB) is approximately 229.5M.

What is the core business model of Aurora Cannabis Inc.?

Aurora Cannabis Inc. operates as an integrated cannabis enterprise, utilizing a vertically integrated model that spans cultivation, processing, and distribution for both medical and recreational markets.

How does Aurora maintain consistent product quality?

The company employs state-of-the-art cultivation techniques, strict GMP manufacturing standards, and rigorous quality control protocols to ensure its products meet high regulatory and safety standards.

Which markets does Aurora Cannabis serve?

Aurora operates in key regions including Canada, Europe, Australia, and South America, with additional initiatives in the United States and other emerging international markets.

What differentiates Aurora’s product portfolio from its competitors?

Aurora’s portfolio is diversified across both consumer and medical cannabis segments, reinforced by science-driven research, innovative product formats, and a commitment to high-quality, compliant production.

What role does research and innovation play at Aurora?

Research and innovation are central to Aurora’s operations, with significant investments in cannabis genetics, advanced cultivation methods, and collaborations with leading academic institutions to drive product improvements.

How does Aurora ensure compliance with regulatory standards?

Aurora adheres to strict regulatory frameworks, including GMP and TGA certifications, and leverages advanced quality control systems to ensure that all products comply with both domestic and international safety standards.

What are some of the major brands under Aurora’s portfolio?

Aurora’s diverse brand portfolio includes recognized names in both the adult-use and medical segments, offering products that range from premium dried flower to innovative consumption formats like oils and pastilles.